137 related articles for article (PubMed ID: 17680992)
1. Inhibition of heat shock proteins (HSP) expression by quercetin and differential doxorubicin sensitization in neuroblastoma and Ewing's sarcoma cell lines.
Zanini C; Giribaldi G; Mandili G; Carta F; Crescenzio N; Bisaro B; Doria A; Foglia L; di Montezemolo LC; Timeus F; Turrini F
J Neurochem; 2007 Nov; 103(4):1344-54. PubMed ID: 17680992
[TBL] [Abstract][Full Text] [Related]
2. Sensitization of human Ewing's tumor cells to chemotherapy and heat treatment by the bioflavonoid quercetin.
Debes A; Oerding M; Willers R; Göbel U; Wessalowski R
Anticancer Res; 2003; 23(4):3359-66. PubMed ID: 12926076
[TBL] [Abstract][Full Text] [Related]
3. In vitro antiproliferative effects of albumin-doxorubicin conjugates against Ewing's sarcoma and peripheral neuroectodermal tumor cells.
Gabor F; Wollmann K; Theyer G; Haberl I; Hamilton G
Anticancer Res; 1994; 14(5A):1943-50. PubMed ID: 7847832
[TBL] [Abstract][Full Text] [Related]
4. Quercetin inhibits heat shock protein induction but not heat shock factor DNA-binding in human breast carcinoma cells.
Hansen RK; Oesterreich S; Lemieux P; Sarge KD; Fuqua SA
Biochem Biophys Res Commun; 1997 Oct; 239(3):851-6. PubMed ID: 9367858
[TBL] [Abstract][Full Text] [Related]
5. C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions.
Scotlandi K; Manara MC; Strammiello R; Landuzzi L; Benini S; Perdichizzi S; Serra M; Astolfi A; Nicoletti G; Lollini PL; Bertoni F; Nanni P; Picci P
J Clin Oncol; 2003 May; 21(10):1952-60. PubMed ID: 12743148
[TBL] [Abstract][Full Text] [Related]
6. A pivotal role for heat shock protein 90 in Ewing sarcoma resistance to anti-insulin-like growth factor 1 receptor treatment: in vitro and in vivo study.
Martins AS; Ordoñez JL; García-Sánchez A; Herrero D; Sevillano V; Osuna D; Mackintosh C; Caballero G; Otero AP; Poremba C; Madoz-Gúrpide J; de Alava E
Cancer Res; 2008 Aug; 68(15):6260-70. PubMed ID: 18676850
[TBL] [Abstract][Full Text] [Related]
7. A midkine promoter-based conditionally replicative adenovirus for treatment of pediatric solid tumors and bone marrow tumor purging.
Adachi Y; Reynolds PN; Yamamoto M; Wang M; Takayama K; Matsubara S; Muramatsu T; Curiel DT
Cancer Res; 2001 Nov; 61(21):7882-8. PubMed ID: 11691808
[TBL] [Abstract][Full Text] [Related]
8. Examination of KNK437- and quercetin-mediated inhibition of heat shock-induced heat shock protein gene expression in Xenopus laevis cultured cells.
Manwell LA; Heikkila JJ
Comp Biochem Physiol A Mol Integr Physiol; 2007 Nov; 148(3):521-30. PubMed ID: 17681842
[TBL] [Abstract][Full Text] [Related]
9. Methylation-associated silencing of the heat shock protein 47 gene in human neuroblastoma.
Yang Q; Liu S; Tian Y; Hasan C; Kersey D; Salwen HR; Chlenski A; Perlman EJ; Cohn SL
Cancer Res; 2004 Jul; 64(13):4531-8. PubMed ID: 15231663
[TBL] [Abstract][Full Text] [Related]
10. The synergistic reversal effect of multidrug resistance by quercetin and hyperthermia in doxorubicin-resistant human myelogenous leukemia cells.
Shen J; Zhang W; Wu J; Zhu Y
Int J Hyperthermia; 2008 Mar; 24(2):151-9. PubMed ID: 18283591
[TBL] [Abstract][Full Text] [Related]
11. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
[TBL] [Abstract][Full Text] [Related]
12. Heat shock-independent induction of multidrug resistance by heat shock factor 1.
Tchénio T; Havard M; Martinez LA; Dautry F
Mol Cell Biol; 2006 Jan; 26(2):580-91. PubMed ID: 16382149
[TBL] [Abstract][Full Text] [Related]
13. Response of human breast cancer cells to heat shock and chemotherapeutic drugs.
Ciocca DR; Fuqua SA; Lock-Lim S; Toft DO; Welch WJ; McGuire WL
Cancer Res; 1992 Jul; 52(13):3648-54. PubMed ID: 1617638
[TBL] [Abstract][Full Text] [Related]
14. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
[TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation and reduced expression of RASSF1A in Ewing sarcoma.
Avigad S; Shukla S; Naumov I; Cohen IJ; Ash S; Meller I; Kollender Y; Issakov J; Yaniv I
Pediatr Blood Cancer; 2009 Dec; 53(6):1023-8. PubMed ID: 19637319
[TBL] [Abstract][Full Text] [Related]
16. Bin1 is linked to metastatic potential and chemosensitivity in neuroblastoma.
Zhong X; Hoelz DJ; Kumar HR; Sandoval JA; Rescorla FJ; Hickey RJ; Malkas LH
Pediatr Blood Cancer; 2009 Sep; 53(3):332-7. PubMed ID: 19418541
[TBL] [Abstract][Full Text] [Related]
17. Effect of overexpression of the small heat shock protein HSP27 on the heat and drug sensitivities of human testis tumor cells.
Richards EH; Hickey E; Weber L; Master JR
Cancer Res; 1996 May; 56(10):2446-51. PubMed ID: 8625326
[TBL] [Abstract][Full Text] [Related]
18. N-myc protein expression in small round cell tumors.
Triche TJ; Cavazzana AO; Navarro S; Reynolds CP; Slamon DJ; Seeger RE
Prog Clin Biol Res; 1988; 271():475-85. PubMed ID: 3406014
[No Abstract] [Full Text] [Related]
19. Proteomic identification of heat shock protein 27 as a differentiation and prognostic marker in neuroblastoma but not in Ewing's sarcoma.
Zanini C; Pulerà F; Carta F; Giribaldi G; Mandili G; Maule MM; Forni M; Turrini F
Virchows Arch; 2008 Feb; 452(2):157-67. PubMed ID: 18066588
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a nitrogen-containing bisphosphonate, minodronate, in conjunction with a p38 mitogen activated protein kinase inhibitor or doxorubicin against malignant bone tumor cells.
Kubo T; Shimose S; Matsuo T; Sakai A; Ochi M
Cancer Chemother Pharmacol; 2008 Jun; 62(1):111-6. PubMed ID: 17874104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
